Contraception News and Research

Latest Contraception News and Research

Management of ovarian cancer risk in women with BRCA1/2 gene mutations

A new review to help physicians manage the risk of ovarian cancer in women who carry the BRCA1/2 gene mutations is published in CMAJ.

12 Aug 2019

Nearly 1 in 8 teens experience reproductive coercion, reports survey

Female adolescents are experiencing relationship abuse at alarming rates, according to a new Michigan State University study that specifically researched reproductive coercion - a form of abuse in which a woman is pressured to become pregnant against her wishes.

9 Aug 2019

FDA approves first therapy for symptomatic tenosynovial giant cell tumor

Today, the U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not responsive to improvement with surgery.

3 Aug 2019

Study uncovers concerning knowledge gaps about birth control effectiveness

A new study has uncovered concerning gaps in knowledge about birth control effectiveness.

29 Jul 2019

New device could help decrease the global burden of unwanted pregnancy

A device that could help decrease the global burden of unwanted pregnancy has been invented by University of Otago academics.

26 Jul 2019

Biden’s ‘incremental’ health plan still would be a heavy lift

The headlines about presidential candidate Joe Biden's new health care plan called it "a nod to the past" and "Affordable Care Act 2.0."

22 Jul 2019

Menstrual cups just as good as sanitary pads or tampons

A new study has shown that menstrual cups are a safe, effective and inexpensive way to deal with menstrual blood flow. The report covered 43 studies and more than 3,300 females. The study titled, 'Menstrual cup use, leakage, acceptability, safety, and availability: a systematic review and meta-analysis, is published in the Lancet Public Health.

18 Jul 2019

Study explores pregnancy-related adverse events associated with acne medication

Isotretinoin (also known by its former brand name as Accutane or Roaccutane) is an extremely effective acne medication that can help patients whose severe acne has not responded to other drugs.

17 Jul 2019

KHN’s ‘What the Health?’: Could the ACA really go away?

The Affordable Care Act was back in court again this week — this time before a three-judge panel at the 5th Circuit Court of Appeals in New Orleans.

11 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Long-acting contraceptives do not increase risk of HIV, concludes new study

One of the largest and most robust studies on HIV infection rates has concluded that long-acting contraceptives do not increase the risk of contracting HIV.

14 Jun 2019

AMA adopts new policies aimed at improving health of the nation

The American Medical Association, the premier national physician organization in the country, voted this week to adopt new policies aimed at improving the health of the nation.

14 Jun 2019

KHN’s ‘What the Health’: Who will pay to fix problem of surprise medical bills?

Congress is finally getting down to real work on legislation to end "surprise" medical bills, which patients get if they inadvertently receive care from an out-of-network health providers or use one in an emergency.

13 Jun 2019

First chemoimmunotherapy regimen approved by FDA for patients with diffuse large B-cell lymphoma

Today, the U.S. Food and Drug Administration granted accelerated approval to Polivy (polatuzumab vedotin-piiq), in combination with the chemotherapy bendamustine and a rituximab product (a combination known as "BR"), to treat adult patients with diffuse large B-cell lymphoma (DLBCL) that has progressed or returned after at least two prior therapies.

10 Jun 2019

Podcast: KHN’s ‘What the Health?’ The state of the abortion debate — a deep dive

Abortion is one of the hottest political issues of 2019. With a newly configured Supreme Court, which many pundits think has the votes to roll back or overturn the landmark 1972 Roe v. Wade ruling, states are rushing either to protect abortion rights or pass laws intended to restrict or ban it.

30 May 2019

UCSF Medical Center backs off plan to deepen ties with Dignity Health

UCSF Medical Center officials said Tuesday they no longer would pursue a formal affiliation with Dignity Health, a large Catholic health care system that restricts care on the basis of religious doctrine.

28 May 2019

Podcast: KHN’s ‘What the Health?’ Is ‘Medicare for All’ losing steam?

A second House committee this week held a hearing on proposals for a single-payer health system, such as “Medicare for All,” featuring experts from the Congressional Budget Office.

23 May 2019

LC-MS/MS test for progesterone outperforms traditional immunoassays

Researchers have devised a cheap, non-invasive and specific means to monitor progesterone production in women.

15 May 2019

Oral contraceptives may reduce risk of ACL tears in women

Oral contraceptives may lower the risk of anterior cruciate ligament tears in women, according to a large observational study involving over 165,000 female patients (aged 15-49), published in The Physician and Sports medicine journal.

30 Apr 2019

Will ties to a Catholic hospital system tie doctors’ hands?

As Catholic health care systems across the country expand, the University of California's flagship San Francisco hospital has become the latest arena for an emotional debate: Should the famously progressive medical center increase its treatment space by joining forces with a Catholic-run system that restricts care according to religious doctrine?

29 Apr 2019